Query Trace: all[original query]

• System for Quantitative Diagnosis of COVID-19-Associated Pneumonia Based on Superpixels With Deep Learning and Chest CT
  Tetila, Everton et al. Research Square December 17 2020
  
• Innate Inhibiting Proteins Enhance Expression and Immunogenicity of Self-Amplifying RNA.
  Blakney Anna K, et al. Molecular therapy : the journal of the American Society of Gene Therapy 2020 12 0.
  
• The management of hematologic malignancies during the COVID-19 pandemic.
  Hus Iwona, et al. Expert opinion on pharmacotherapy 2020 12 0. 1-18
  
• Increased levels of plasma cytokines and correlations to organ failure and 30-day mortality in critically ill Covid-19 patients.
  Bülow Anderberg Sara, et al. Cytokine 2020 12 0. 155389
  
• Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
  Lay Mendoza Maria Fernanda, et al. Viruses 2020 12 0. (12)
  
• Structure-Based Screening to Discover New Inhibitors for Papain-like Proteinase of SARS-CoV-2: An In Silico Study.
  Jamalan Mostafa, et al. Journal of proteome research 2020 12 0.
  
• Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre study.
  Jirak Peter, et al. ESC heart failure 2020 12 0.
  
• Prognostic Value of Troponin Elevation in COVID-19 Hospitalized Patients.
  Cordeanu Elena-Mihaela, et al. Journal of clinical medicine 2020 12 0. (12)
  
• Care of Cystic Fibrosis Children in COVID-19 Pandemic.
  Kumar Prawin, et al. Turkish thoracic journal 2020 11 0. (6) 461-462
  
• The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network.
  Pearson Kelsie, et al. Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society 2020 12 0.
  
• Does tetanus vaccination contribute to reduced severity of the COVID-19 infection?
  Rickett Christopher D, et al. Medical hypotheses 2020 11 0. 110395
  
• Cross-border COVID-19 spread amidst malaria re-emergence in Venezuela: a human rights analysis.
  Correa-Salazar Catalina, et al. Globalization and health 2020 0 0. (1) 118
  
• SARS-CoV-2 and Viral Sepsis: Immune Dysfunction and Implications in Kidney Failure.
  Stasi Alessandra, et al. Journal of clinical medicine 2020 12 0. (12)
  
• The broad spectrum host-directed agent ivermectin as an antiviral for SARS-CoV-2 ?
  Jans David A, et al. Biochemical and biophysical research communications 2020 10 0.
  
• Wildland firefighter exposure to smoke and COVID-19: A new risk on the fire line.
  Navarro Kathleen M, et al. The Science of the total environment 2020 12 0. 144296
  
• Renin-angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis.
  Morales Daniel R, et al. The Lancet. Digital health 2020 12 0.
  
• No significant association between dipeptidyl peptidase-4 inhibitors and adverse outcomes of COVID-19.
  Zhou Jiang-Hua, et al. World journal of clinical cases 2020 11 0. (22) 5576-5588
  
• Possible therapeutic interventions in COVID-19 induced ARDS by cotinine as an ACE-2 promoter and AT-1R blocker.
  Sharma Tarun, et al. Infectious disorders drug targets 2020 12 0.
  
• MIS-C: early lessons from immune profiling
  LA Henderson et al, Nat Rev Rheumatology, December 2020
  
  Multisystem inflammatory syndrome in children (MIS-C) is a rare complication of SARS-CoV-2 infection that can result in serious illness in the pediatric population but our understanding of this syndrome is in its infancy. MIS-C and Kawasaki disease might share plasma protein profiles but differ in autoantibody targets.
• Human Leukocyte Antigen Complex and Other Immunogenetic and Clinical Factors Influence Susceptibility or Protection to SARS-CoV-2 Infection and Severity of the Disease Course. The Sardinian Experience.
  Littera Roberto, et al. Frontiers in immunology 2020 0 0. 605688
  
• Establishing a telerehabilitation program for patients with Duchenne muscular dystrophy in the COVID-19 pandemic.
  Sobierajska-Rek Agnieszka, et al. Wiener klinische Wochenschrift 2020 12 0.
  
• Diagnostic testing for SARS-CoV-2 infection in HHT patients: nasopharyngeal versus oropharyngeal swab.
  Pagella Fabio, et al. Orphanet journal of rare diseases 2020 12 0. (1) 350
  
• Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2.
  Zhu Yue, et al. Frontiers in plant science 2020 0 0. 601316
  
• COVID-19, Antiphospholipid Antibodies, and Catastrophic Antiphospholipid Syndrome: A Possible Association?
  El Hasbani Georges, et al. Clinical medicine insights. Arthritis and musculoskeletal disorders 2020 0 0. 1179544120978667
  
• Ethnic and age-specific acute lung injury/acute respiratory distress syndrome risk associated with angiotensin-converting enzyme insertion/deletion polymorphisms, implications for COVID-19: A meta-analysis.
  Pabalan Noel, et al. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2020 12 0. 104682
  
• Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
  Matangila Junior Rika, et al. PloS one 2020 0 0. (12) e0244272
  
• Bioactivity Potential of Marine Natural Products from Scleractinia-Associated Microbes and In Silico Anti-SARS-COV-2 Evaluation.
  Zahran Eman Maher, et al. Marine drugs 2020 12 0. (12)
  
• Genetic and Acquired Heterotopic Ossification: A Translational Tale of Mice and Men.
  Cappato Serena, et al. Biomedicines 2020 12 0. (12)
  
• [Response of the Catalonia neonatal screening laboratory to the pandemic of SARS-CoV-2.]
  Argudo Ramírez Ana, et al. Revista espanola de salud publica 2020 12 0.
  
• A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection.
  Ghosh Ritwik, et al. Journal of neuroimmunology 2020 11 0. 577439